AngioDynamics Balance Sheet Health
Financial Health criteria checks 6/6
AngioDynamics has a total shareholder equity of $218.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $324.8M and $106.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$78.45m |
Equity | US$218.70m |
Total liabilities | US$106.14m |
Total assets | US$324.84m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: UG2's short term assets ($196.9M) exceed its short term liabilities ($85.9M).
Long Term Liabilities: UG2's short term assets ($196.9M) exceed its long term liabilities ($20.3M).
Debt to Equity History and Analysis
Debt Level: UG2 is debt free.
Reducing Debt: UG2 has no debt compared to 5 years ago when its debt to equity ratio was 24%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: UG2 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: UG2 has sufficient cash runway for 2.3 years if free cash flow continues to reduce at historical rates of 46.4% each year.